Anti-TSH receptor antibodies in clinical practice

Endocrinology and Metabolism Clinics of North America

Volumn 29, Issue 2, 2000, Pages 339-355

  Orgiazzi, Jacques ^b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTITHYROID AGENT; CYCLIC AMP; RADIOACTIVE IODINE; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ANTIBODY TITER; CLINICAL PRACTICE; CONGENITAL HYPOTHYROIDISM; DISEASE MARKER; DISEASE SEVERITY; GRAVES DISEASE; HASHIMOTO DISEASE; HEPATITIS B; HUMAN; IATROGENIC DISEASE; PREGNANCY; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; REMISSION; REVIEW; SUBACUTE THYROIDITIS; THYROID CARCINOMA; THYROIDECTOMY; TOXIC GOITER;

EID: 0034042725     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70135-3     Document Type: Article

References (90)

1. Y. Aizawa K. Yoshida N. Kaise Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease Clin Endocrinol 42 1995 517
2. Y. Aizawa K. Yoshida N. Kaise The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: Prevalence, mechanism and prognosis Clin Endocrinol 46 1997 1
3. H. Allannic Y. Lorcy A.M. Leguerrier Antithyroidiens de synthèse et maladie de Basedow ou le choix d'une stratégie thérapeutique Presse Med 20 1991 645
4. E. Baudin P. Marcellin M. Pouteau Reversibility of thyroid function induced by recombinant alpha interferon in chronic hepatitis C Clin Endocrinol 39 1993 657
5. W.H. Beierwaltes V.N. Dodson A.H. Wheeler Thyroid autoantibodies in the families of cretins J Clin Endocrinol Metab 19 1959 179
6. G. Benker P. Vitti G. Kahaly Response to methimazole in Graves' disease Clin Endocrinol 43 1995 257
7. 3 index, thyroid volume, and thyroid stimulating, TSH receptor binding and thyroid growth stimulating antibodies in untreated Graves' disease Clin Endocrinol 27 1987 75
8. H.B. Burch L. Wartofsky Graves' ophthalmopathy: Current concepts regarding pathogenesis and management Endocr Rev 14 1993 747
9. G.D. Chazenbalk J.C. Jaume S.M. McLachlan Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glucoprotein that neutralizes autoantibodies in Graves patients' sera J Biol Chem 272 1997 18959
10. F.Q. Chen K. Okamura K. Sato Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon therapy in patients with pre-existing thyroid disorders Clin Endocrinol 45 1996 207
11. L. Chiovato E. Fiore P. Vitti Outcome of thyroid function in Graves' patients treated with radioiodine: Role of thyroid-stimulating and thyrotropin-blocking antibodies and radioiodine-induced thyroid damage J Clin Endocrinol Metab 83 1998 40
12. L. Chiovato F. Santini P. Vitti Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre Clin Endocrinol 40 1994 803
13. L. Chiovato P. Vitti F. Santini Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis J Clin Endocrinol Metab 71 1990 40
14. B.Y. Cho W.B. Kim J.H. Chung High prevalence and little change in TSH receptor blocking antibody titres with thyroxine and antithyroid drug therapy in patients with non-goitrous autoimmune thyroiditis Clin Endocrinol 43 1995 465
15. B.Y. Cho M.H. Shong K.H. Yi Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease Clin Endocrinol 36 1992 585
16. R. Clague E.D. Mukhtar G.A. Pyle Thyroid-stimulating immunoglobulin and the control of thyroid function J Clin Endocrinol Metab 43 1976 550
17. A.J. Coles M.G. Wing S. Smith Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis Lancet 354 1999 1691
18. S. Costagliola N.G. Morgenthaler R. Hoermann Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease J Clin Endocrinol Metab 84 1999 90
19. F. Daffos M. Capella-Pavlovsky F. Forestier Fetal blood sampling during pregnancy with the use of a needle guided by ultrasound: A study of 606 consecutive cases Am J Obstet Gynecol 153 1985 655
20. K.M. Davidson D.S. Richards D.A. Schatz Successful in utero treatment of fetal goiter and hypothyroidism N Engl J Med 324 1991 543
21. R. De Forteza C.U. Smith J. Amin Visualization of the thyrotropin receptor on the cell surface by potent autoantibodies (published erratum appears in J Clin Endocrinol Metab 78:376, 1994) J Clin Endocrinol Metab 78 1994 1271
22. S.M. Dirmikis D.S. Munro Placental transmission of thyroid-stimulating immunoglobulins BMJ 2 1975 665
23. B. Ducornet A. Moisson-Meer J. Duprey Hypothyroidism and blocking thyrotropin receptor antibodies Ann Med Interne (Paris) 146 1995 558
24. J.E. Dumont F. Lamy P. Roger Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors Physiol Rev 72 1992 667
25. G. Edan C. Massart B. Hody Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease BMJ 298 1989 359
26. C. Evans N.G. Morgenthaler S. Lee Development of a luminescent bioassay for thyroid stimulating antibodies J Clin Endocrinol Metab 84 1999 374
27. U. Feldt-Rasmussen D. Glinoer J. Orgiazzi Reassessment of antithyroid drug therapy of Graves' disease Annu Rev Med 44 1993 323
28. U. Feldt-Rasmussen H. Schleusener P. Carayon Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease J Clin Endocrinol Metab 78 1994 98
29. V. Fonseca M. Thomas G. Dusheiko Thyrotropin receptor antibodies following treatment with recombinant alpha-interferon in patients with hepatitis Acta Endocrinol 125 1991 491
30. A. Gamstedt A. Karlsson Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: Thyroid autoantibody responses and outcome of therapy J Clin Endocrinol Metab 73 1991 125
31. J. Gilquin J.P. Viard V. Jubault Delayed occurrence of Graves' disease after immune restoration with HAART: Highly active antiretroviral therapy Lancet 352 1998 1907
32. N.S. Glaser D.M. Styne Predictors of early remission of hyperthyroidism in children J Clin Endocrinol Metab 82 1997 1719
33. D. Glinoer The regulation of thyroid function in pregnancy: Pathways of endocrine adaptation from physiology to pathology Endocr Rev 18 1997 404
34. A.A.E. Gossage J.C.W. Crawley S. Copping Thyroid function and immunological activity during and after medical treatment of Graves' disease Clin Endocrinol 19 1983 87
35. K. Hashizume K. Ichikawa A. Sakurai Administration of thyroxine in treated Graves' disease: Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism N Engl J Med 324 1991 947
36. A.J. Hedley R.E. Young S.J. Jones Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: Long-term follow-up of 434 patients Clin Endocrinol 31 1989 209
37. L. Hegedus J.M. Hansen K. Bech Thyroid stimulating immunoglobulins in Graves' disease with goitre growth, low thyroxine and increasing triiodothyronine during PTU treatment Acta Endocrinol 107 1984 482
38. K. Hoekman B.M.E. Von Blomberg-Van der Flier J. Wagstaff Reversible thyroid dysfunction during treatment with GM-CSF Lancet 338 1991 541
39. A. Ilicki A. Gamstedt F.A. Karlsson Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies J Clin Endocrinol Metab 74 1992 1090
40. F. Ishikawa H. Shigematsu H. Gondo Autoreactive antibodies following autologous peripheral blood stem cell transplantation Bone Marrow Transplant 22 1998 729
41. M. Itaka N. Momotani T. Hisaoka TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis Clin Endocrinol 48 1998 445
42. J.C. Jaume A. Kakinuma G.D. Chaenbalk Thyrotropin receptor autoantibodies in serum are present at much lower levels than thyroid peroxidase autoantibodies: Analysis by flow cytometry J Clin Endocrinol Metab 82 1997 500
43. F.A. Karlsson P.A. Dahlberg Thyroid stimulating antibodies (TSAb) in patients with Graves' disease undergoing antithyroid drug treatment—indicators of activity of disease Clin Endocrinol 14 1981 579
44. K. Kasagi A. Hidaka K. Endo Fluctuating thyroid function depending on the balance between stimulating and blocking type of TSH receptor antibodies: A case report Thyroid 3 1993 315
45. K. Kasagi A. Hidaka H. Nakamura Thyrotropin receptor antibodies in hypothyroid Graves' disease J Clin Endocrinol Metab 75 1993 504
46. K. Kawai H. Tamai S. Matsubayashi A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs Clin Endocrinol 43 1995 551
47. K. Kawai H. Tamai T. Mori Thyroid histology of hyperthyroid Graves' disease with undetectable thyrotropin receptor antibodies J Clin Endocrinol Metab 77 1993 716
48. Z. Kraiem E. Baron L. Kahana Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo- to hyperthyroidism and back to hypothyroidism Clin Endocrinol 36 1992 214
49. Z. Kraiem B. Glaser M. Yigla Toxic multinodular goiter: A variant of autoimmune hyperthyroidism J Clin Endocrinol Metab 65 1987 659
50. A.W.C. Kung B.M. Jones A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy J Clin Endocrinol Metab 83 1998 514
51. B. Laferrere A.M. Madec J. Orgiazzi Critères biologiques de l'ophtalmopathie basedowienne isolée Presse Med 16 1987 711
52. P. Laurberg B. Nygaard D. Glinoer Guidelines for TSH-receptor antibody measurements in pregnancy: Results of an evidence-based symposium organized by the European Thyroid Association Eur J Endocrinol 139 1998 584
53. M. Lisker-Melman A.M. Di-Biseglie S.J. Usala Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha Gastroenterology 102 1992 2155
54. A. Lucas I. Salinas F. Rius Medical therapy of Graves' disease: Does thyroxine prevent recurrence of hyperthyroidism? J Clin Endocrinol Metab 82 1997 2410
55. M. Ludgate M. Crisp S. Lane The TSH receptor in thyroid eye disease Thyroid 8 1998 411
56. E. Macchia G.F. Fenzi F. Monzani Comparison between thyroid stimulating and TSH-binding inhibiting immunoglobulins of Graves' disease Clin Endocrinol 15 1981 175
57. N. Matsuura J. Konishi K. Fujieda TSH-receptor antibodies in mothers with Graves' disease and outcome in their offspring Lancet 9 1988 14
58. N. Matsuura J. Konishi K. Uri Comparison of atrophic and goitrous autoimmune thyroiditis in children: Clinical, laboratory and TSH-receptor antibody studies Eur J Pediatr 149 1990 529
59. N. Matsuura Y. Yamada Y. Nohara Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins N Engl J Med 303 1980 738
60. B. McIver P. Rae G. Beckett Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug N Engl J Med 334 1996 220
61. J.M. McKenzie M. Zakarija Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies Thyroid 2 1992 155
62. J.H. Mestman M. Goodwin M.M. Montoro Thyroid disorders of pregnancy Endocrinol Metab Clin North Am 24 1995 41
63. V. Michelangeli C. Poon J. Taft The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs Thyroid 8 1998 119
64. V.P. Michelangeli C. Poon D.J. Topliss Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease Thyroid 5 1995 171
65. N.G. Morgenthaler J. Tremble G.C. Huang Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: Ability to map epitopes recognised by antibodies J Clin Endocrinol Metab 81 1996 700
66. Y. Mori N. Matoba S. Miura Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease World J Surg 16 1992 647
67. T. Morita H. Tamai A. Oshima The occurrence of thyrotropin binding-inhibiting immunoglobulins and thyroid-stimulating antibodies in patients with silent thyroiditis J Clin Endocrinol Metab 71 1990 1051
68. T. Mukuta H. Tamai A. Oshima Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin Clin Endocrinol 40 1994 215
69. Y. Murakami J. Takamatsu S. Sakane Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome J Clin Endocrinol Metab 81 1996 3257
70. 131I treatment in patients with nontoxic goiter J Clin Endocrinol Metab 82 1997 2926
71. S.A. Patibandla J.S. Dallas G.S. Seetharamaiah Flow cytometric analyses of antibody binding to Chinese hamster ovary cells expressing human thyrotropin receptor J Clin Endocrinol Metab 82 1997 1885
72. G. Pellegriti A. Belfiore D. Giuffrida Outcome of differentiated thyroid cancer in Graves' patients J Clin Endocrinol Metab 83 1998 2805
73. M. Polak J. Leger D. Luton Fetal cord blood sampling in the diagnosis and the treatment of fetal hyperthyroidism in the offsprings of a euthyroid mother, producing thyroid stimulating immunoglobulins Ann Endocrinol 58 1997 338
74. B. Rapoport G. Chazenbalk J.C. Jaume The thyrotropin (TSH)-releasing hormone receptor: Interaction with TSH and autoantibodies Endocr Rev 19 1998 673
75. M. Rieu A. Raynaud A. Richard Evidence for the effect of antibodies to TSH receptors on the thyroid ultrasonographic volume in patients with Graves' disease Clin Endocrinol 41 1994 667
76. R.S. Rittmaster H. Zwicker E.C. Abbot Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease J Clin Endocrinol Metab 81 1996 3283
77. S.A. Rivkees C. Sklar M. Freemark The management of Graves' disease in children, with special emphasis on radioiodine treatment J Clin Endocrinol Metab 83 1998 3767
78. L.E. Ronnblom G.V. Alm K.E. Oberg Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors Ann Intern Med 115 1991 178
79. H. Schleusener J. Schwander C. Fischer Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease Acta Endocrinol 120 1989 689
80. N.R. Steel J.J. Taylor E.T. Young The effect of subtotal thyroidectomy with propranolol preparation on antibody activity in Graves' disease Clin Endocrinol 26 1987 97
81. K. Sugino T. Mimura O. Ozaki Preoperative change of thyroid stimulating hormone receptor antibody level: Possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy World J Surg 20 1996 801
82. N. Takasu T. Yamada M. Takasu Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis N Engl J Med 326 1992 513
83. H. Tamai Y. Hirota K. Kasagi The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment J Clin Endocrinol Metab 64 1987 718
84. H. Tamai T. Nozaki T. Mukuta The incidence of thyroid stimulating blocking antibodies during the hypothyroid phase in patients with subacute thyroiditis J Clin Endocrinol Metab 73 1991 245
85. O. Törring L. Tallstedt G. Wallin Graves' hyperthyroidism: Treatment with antithyroid drugs, surgery or radioiodine—a prospective, randomized study J Clin Endocrinol Metab 81 1996 2986
86. P. Vitti T. Rago L. Chiovato Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment Thyroid 3 1997 369
87. P.F. Watson R.A. Ajjan R. Phipps A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease Clin Endocrinol 49 1998 577
88. Y. Yamaguchi T. Inukai A. Iwashita Changes in thyroid volume during antithyroid drug therapy for Graves' disease and its relationship to TSH receptor antibodies, TSH and thyroglobulin Acta Endocrinol 123 1990 411
89. 131I treatment for Graves' disease Clin Endocrinol 48 1998 17
90. M. Zakarija J.M. McKenzie The spectrum and significance of autoantibodies reacting with the thyrotropin receptor Endocrinol Metab Clin North Am 16 1987 343